BioLife Solutions (BLFS) Stock: Buy, Sell, or Hold?
BLFS - BioLife Solutions Inc.
$37.82
1.03 (2.81%)
▲
5d:
-1.75%
30d:
+5.28%
90d:
+36.07%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When BLFS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BLFS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BLFS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.07
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$9.98
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLFS is currently trading at $37.81, which is considered extended relative to its 30-day fair value range of $35.48 to $37.79. The stock's valuation (Forward PE: 111.5) is in line with its historical norms (108.6). At these levels, the market is pricing in 0.9% annual earnings growth.
Technical Outlook: Technically, BLFS is in a strong uptrend. Immediate support is located at $36.53, while resistance sits at $39.76.
Market Sentiment: BLFS scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $31.29. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BLFS is in a strong uptrend. Immediate support is located at $36.53, while resistance sits at $39.76.
Market Sentiment: BLFS scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $31.29. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$35.48 -
$37.79
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
22.4%
Protect Your Profits
Holding BLFS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (27/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 14.9% above Wall St target ($31.29)
- BULLISH: Expecting earnings turnaround to 0.9% growth with 21.5% revenue growth
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$35.48 -
$37.79
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$36.53
Resistance Level
$39.76
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
111.45
Wall Street Target
$31.29
(-14.9%)
Revenue Growth (YoY)
21.5%
Earnings Growth (YoY)
-13.9%
Profit Margin
54.4%
Valuation Premium vs History
+0.9% premium
PE vs Historical
111.5 vs 108.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.9%
(market-implied from PE analysis)
1-Year Target
$37.11
(+1%)
2-Year Target
$37.45
(+2%)
3-Year Target
$37.78
(+3%)
3-Yr Target (if PE normalizes)
(PE: 111→109)
PE COMPRESSION
$36.81
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 111.5, Growth: 32.0%)
$84.59
(+130%)
Base:
(SPY PE: 20.4, Growth: 32.0%)
$15.48
(-58%)
Bear:
(PE: 17.3, Growth: 32.0%)
$13.16
(-64%)
📈
Valuation based on Current Earnings
Trailing PE: 38.85 | Current EPS (TTM): $1.00
Bull Case
$21.37
(-42%)
Analyst growth -50.0%, PE expands to 42.7
Base Case
$19.43
(-47%)
Market implied -50.0%, PE stable at 38.9
Bear Case
$26.42
(-28%)
Severe decline -20.0%, PE contracts to 33.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 02, 2026 10:39 AM ET
Data refreshes hourly during market hours. Next update: 11:39 AM
Data refreshes hourly during market hours. Next update: 11:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLFS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 50 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 33 SELL |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 62 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 58 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$408 | 52 HOLD |
Advanced BLFS Option Strategies
Professional options setups generated by AI based on today's BLFS price and gamma walls.
